A left-wing group representing the interests of Arab-Americans filed a lawsuit against the Trump administration in an attempt ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

Shaheed Benazirabad, Hassan Zafar, chaired a meeting at DC office on Monday to formulate the program of grand celebrations of March 23, Pakistan Resolution Day in the district. Speaking on the ...

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

The African Diplomatic Corps (ADC) and the United Nations Mission in South Sudan (UNMISS) have called on parties to the South ...

The ADC has filed a lawsuit against two executive orders by President Trump, arguing they threaten free speech ...

Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is ...

SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will be exercising its ...

In the 2025 LCK Cup, Gumayusi only played five matches compared to Smash, who played 15 matches including the playoffs against Hanwha Life Esports, where T1 was eliminated. HLE went on to win the ...

Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate ...